AI assistant
Sending…
Sight Sciences, Inc. — Director's Dealing 2021
Jul 15, 2021
33763_dirs_2021-07-14_33dea384-63a2-48d2-9049-b2d88c6470a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-14
Reporting Person: Offer Andrew (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 129310 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series C Redeemable Convertible Preferred Stock | $ | Common Stock (3162) | Direct | ||
| Series A Redeemable Convertible Preferred Stock | $ | Common Stock (2173912) | Indirect | ||
| Series B Redeemable Convertible Preferred Stock | $ | Common Stock (51840) | Indirect |
Footnotes
F1: The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.
More from Sight Sciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Regulatory Filings
2026
May 29
Report Publication Announcement
2026
May 6
Legal Proceedings Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 22
Legal Proceedings Report
2026
Mar 30
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 5